Many thanks Hadrian, tour work on and analysis of Mayne Pharma is very much appreciated.
I have to confess your graph above triggered me. I invested just after the peak when MYX invested in generics, which thought was a great sector to expand into. I could not have been more wrong. And little did I know how hopeless our previous CEO was and how ineffectual our previous Chairman was.
But I kept the faith and then along came Nextstellis. I believe that Nextstellis will be a great asset for MYX and I like the new Board and CEO and CFO. And I have never sold a share.
The recent sell off is part of the ups and downs of investing and investor sentiment. It has been a very severe down caused by mass confusion in the recent presentation and ensuing explanation and confirmation of forecasts.
I don't reckon the market bought that at all, hence the severe sell off. This will now not reverse until June results are in and the market can digest them and understand them.
Even if MYX achieve forecast we will not see a re-rate until the AGM when a forecast or some insights into FY'25 early trading can be gleaned.
That's my take and please, keep up the good work. Eventually we will be rewarded.
Cheers......D
MYX Price at posting:
$4.77 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)